Joseph Belanoff Net Worth & Insider Trades
Joseph Belanoff - Chief Executive Officer, Corcept Therapeutics Inc
What is Joseph Belanoff's Net Worth?
The current estimated net worth of Corcept Therapeutics Inc's Chief Executive Officer, Joseph Belanoff, is estimated to be about $88.6M . Joseph Belanoff owns about 2,464,195 units of Corcept Therapeutics Inc common stock. In the last 2 years at Corcept Therapeutics Inc, Joseph Belanoff has sold an estimated value of $1.05M worth.
What is Joseph Belanoff's Past Insider Trading?
Joseph Belanoff's largest sale order was 10,000 units , worth over $57.93K on December 9, 2004. In total, Joseph Belanoff has made about 69 transactions over 2 years of their time at Corcept Therapeutics Inc. Joseph Belanoff usually trades in March, with the busiest year in 2006. The most recent transaction was a sale order of 10,000 units , worth over $8.68K on November 21, 2006.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Joseph K Belanoff
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Joseph Belanoff's Salary in 2020?
As Chief Executive Officer of Corcept Therapeutics Inc, Joseph Belanoff has a total base salary of $769,567 . Joseph Belanoff received compensation valued at about $5,762,102 in 2020 after becoming Chief Executive Officer. The vast majority of their compensation came in the form of a bonus of $744,000 , option awards of $4,237,643 , and other compensation of $10,892 .
What is Joseph Belanoff's' Mailing Address?
- Mailing address is 149 Commonwealth Drive Menlo Park CA 94025 CA
Corcept Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Joseph K. Belanoff, M.D., | 2020 | $769,567 | $744,000 | $4,237,643 | $10,892 | $5,762,102 |
| Joseph K. Belanoff, M.D., | 2019 | $707,525 | $745,290 | $3,506,155 | - | $4,958,970 |
| Joseph K. Belanoff, M.D., | 2018 | $679,792 | $477,750 | $5,157,075 | - | $6,314,617 |
| Andreas Grauer, M.D., | 2020 | $454,550 | $219,157 | $1,271,293 | $118,274 | $2,063,274 |
| Andreas Grauer, M.D., | 2019 | $362,267 | $243,720 | $3,115,335 | $78,245 | $3,799,567 |
| Hazel Hunt, Ph.D., | 2020 | $431,873 | $243,000 | $2,084,640 | - | $2,759,513 |
| Sean Maduck, | 2020 | $474,380 | $214,157 | $2,508,404 | - | $3,196,941 |
| Sean Maduck, | 2019 | $456,133 | $308,881 | $1,476,276 | - | $2,241,290 |
| Sean Maduck, | 2018 | $436,667 | $198,000 | $2,171,400 | - | $2,806,067 |
| Charles Robb, | 2020 | $474,380 | $321,236 | $2,118,822 | - | $2,914,438 |
| Charles Robb, | 2019 | $456,133 | $308,881 | $1,845,345 | - | $2,610,359 |
| Charles Robb, | 2018 | $436,667 | $237,600 | $2,171,400 | - | $2,845,667 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1088856/000162828021007363/a2021def14a.htm
What are Corcept Therapeutics Inc's Past Insider Trades?
Corcept Therapeutics Inc's most recent insider trade came on November 3, 2023 by Joseph Douglas Lyon who sold 5,000 units worth $140.52K . In the last 19 years, insiders at Corcept Therapeutics Inc have sold an estimated value of $205.7M and bought an estimated value of $188.56M worth of shares. Insider trading is most common in February, with the busiest year in 2006. The most active traders at the company are Joseph K Belanoff, Chief Executive Officer, Robert Roe, President and Secretary, and Leonard Baker Jr, Director .
CORCEPT THERAPEUTICS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||